Management of Rheumatoid Arthritis
Authors:
- Christopher I CarswellCCChristopher I Carswell
- Tim IbbotsonTITim Ibbotson
- 1 January 2003
- journal article
- Published by Springer Nature in Disease Management and Health Outcomes
- Vol. 11 (11) , 745-765
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritisArthritis & Rheumatism, 2002
- Economic Comparison of Leflunomide and Methotrexate in Patients with Rheumatoid ArthritisPharmacoEconomics, 2002
- A Review of the Direct Costs of Rheumatoid ArthritisPharmacoEconomics, 2001
- Muscle Relaxation Training and Quality of Life in Rheumatoid Arthritis: A randomized controlled clinical trialScandinavian Journal of Rheumatology, 1999
- REGULATION OF B CELL FUNCTION BY THE IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1Transplantation, 1996
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- The clinical and health status of patients with recent‐onset rheumatoid arthritisArthritis & Rheumatism, 1991
- Disease-modifying Anti-rheumatic Drug Therapy: An Expensive Therapy despite Inexpensive DrugsScandinavian Journal of Rheumatology, 1990
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Measurement of patient outcome in arthritisArthritis & Rheumatism, 1980